Olink’s protein biomarker technology to provide proteomics data from 53,000 participants

Neon face paint splatter

The Olink Proteomics Olink Explore 1536 platform, using Next Generation Sequencing (NGS) as read-out, will be used in a project to measure plasma protein concentration in 53,000 individuals from the UK Biobank, one of the world’s largest genetic resources. The project is funded by a consortium of ten biopharmaceutical companies.